Hara Capital’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$156K Sell
4,056
-11,297
-74% -$466K 0.08% 133
2025
Q4
$631K Hold
15,353
0.35% 70
2025
Q3
$572K Sell
15,353
-360
-2% -$13.1K 0.34% 71
2025
Q2
$573K Sell
15,713
-1,500
-9% -$54.4K 0.36% 62
2025
Q1
$665K Sell
17,213
-26,673
-61% -$1.06M 0.45% 51
2024
Q4
$1.66M Buy
+43,886
New +$1.75M 0.53% 41

Other funds holding BME

Hara Capital's BME Position: Q1 2026 in Review

Hara Capital reduced its BlackRock Health Sciences Trust (BME) stake by 74% in Q1 2026, selling an estimated $466K and leaving 4,056 shares worth $156K. The position accounts for 0.08% of the portfolio, ranked #133.

Hara Capital first reported a position in BME in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.66M in Q4 2024. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Hara Capital held 4,056 shares of BlackRock Health Sciences Trust worth $156K as of Q1 2026.
  • Hara Capital sold 11,297 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $466K.
  • BlackRock Health Sciences Trust made up 0.08% of Hara Capital's portfolio in Q1 2026, its #133 holding.
  • Hara Capital first reported a position in BlackRock Health Sciences Trust in Q4 2024 and has held it in 6 quarters since.
  • Hara Capital's BlackRock Health Sciences Trust position peaked at $1.66M in Q4 2024.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Hara Capital's 13F filing for Q1 2026, filed 14 May 2026.